Dr. James Snider

Chief Medical Officer

James W. (J.W.) Snider, III, M.D. is the Chief Medical Officer at Proton International who specializes in Proton Therapy and the treatment of numerous malignancies including Head/Neck Cancer, Prostate Cancer, Sarcomas, Breast Cancer, Lung Cancer, and Spine malignancies. Dr. Snider previously served as the Medical Director of Proton International at UAB in Birmingham, AL and Radiation Oncologist at SFPTI.

Dr. Snider completed two bachelor degrees at the University of Alabama before attending the Georgetown University School of Medicine. He performed his internship at Georgetown/INOVA Fairfax Hospital. Dr. Snider completed his residency training in Radiation Oncology at the University of Maryland Medical Center, serving as Chief Resident. Dr. Snider was also selected for and completed a Clinical/Research Proton Fellowship at the world-renowned Paul Scherrer Institute Center for Proton Therapy in Villigen, Switzerland – the birthplace of the pencil beam scanning technology utilized at SFPTI. He subsequently was on faculty at the University of Maryland as an Assistant Professor radiation oncologist. He then joined the University of Alabama at Birmingham radiation oncology team as an Associate Professor and the Associate Medical Director for Proton Therapy.

Dr. Snider’s research has focused on Pencil Beam Scanning Proton Therapy, Stereotactic Radiotherapy, Spatially Fractionated Radiotherapy, Head/Neck Cancer, Sarcomas, Concurrent Thermoradiotherapy, Spine Tumors, Proton Therapy efficiency/workflow improvement, and unique treatment/device-development. Dr. Snider has published numerous peer-reviewed articles in these arenas, and he has given many national/international presentations of this work. He has also received numerous awards and honors from The Radiosurgery Society, International Congress for Hyperthermic Oncology, and the Radiological Society of North America, to name a few. On a national level, Dr. Snider is an active member, serving on numerous boards and committees, for the Particle Therapy Co-Operative Group (PTCOG), PTCOG-NA, Radiosurgery Society, Chondrosarcoma Foundation, National Association for Proton Therapy, and the American Society for Radiation Oncology.